One previous study demonstrated that the upregulated DEG CAMK2N1 is linked with poor OS and progression-free interval (PFI) of high-risk squamous cell carcinoma patients (Feng et al., 2021). Here, CAMK2N1 is linked to squamous cell carcinoma.